‘Cohesive Paste™’: A Product with Enhanced Comfort and Skin Protection for Stoma Patients

Impact: Quality of Life Impact, Economic Impact, Health Impact

Narrative

In the UK approximately 100, 000 people have a stoma, an artificial opening in the bowel that is used to divert the flow of exudate prior to subsequent external collection. Stoma exudate is a corrosive fluid, which varies in pH and enzyme content. Therefore, it is important that the stoma seal adhesive paste operates successfully within a diverse range of physiological conditions. The novel stoma adhesive developed by Jones and colleagues through KTP funded research in the
School of Pharmacy was launched by Eakin as Cohesive Paste ™ and is now sold in 26 countries, with sales of more than £1M to date.
Impact statusOngoing
Category of impactQuality of Life Impact, Economic Impact, Health Impact
Impact levelAdoption

Related content